BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioBridge Knowledge Platform - ECPv5.10.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioBridge Knowledge Platform
X-ORIGINAL-URL:https://library.biobridge-event.com/knowledge
X-WR-CALDESC:Events for BioBridge Knowledge Platform
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20211122T190000
DTEND;TZID=Europe/Paris:20211122T200000
DTSTAMP:20260514T012105
CREATED:20211104T132130Z
LAST-MODIFIED:20211104T132130Z
UID:12389-1637607600-1637611200@library.biobridge-event.com
SUMMARY:Cellular Matrix innovation for Osteoarthritis management
DESCRIPTION:Intra-articular injections of PRP offer a holistic approach that may have a simultaneous impact on several etiologic factors of osteoarthritis. The myriad of growth factors and biomolecules in PRP have the potential to disrupt the inflammatory loop associated with osteoarthritis and recover joint homeostasis\, which is essential for creating a favorable environment for cartilage regeneration and reducing pain (Chen et al.\, 2017). \nPRP for therapeutic use is anticoagulated with citrate-based anticoagulants. This anticoagulation has the advantage of being fully reversible and with no ancillary effect on the patient. PRP coagulation occurs spontaneously at the site of PRP injection. This results in the formation of fibrin clots in which platelets are entrapped and allows the sustained release of growth factors over time (Perez et al.\, 2014b). \nThe interest for combining the biological effect of PRP with HA viscosupplementation emerged in the last decade. To respond to this interest\, Regen Lab developed a new medical device\, Cellular Matrix. \n\n\n					\n				\n					\n						Our Speaker\n\n\nProf Armin Keshmiri\,  \nSpecialist in Orthopaedics and Trauma Surgery\, Chirotherapy (Germany) \n\n\n\n\n					\n				\n					\n						TOPICS DISCUSSED : \nI) Cellular Matrix innovation for Osteoarthritis management\n(Mr Gomri\, Biologist\, 5 min)\nA compilation of clinical evidence\, cases and testimonies with the use of a standardized PRP-HA combination in OA. \nII) Prof Armin Keshmiri expertise in the use of Cellular Matrix in OA\n(Prof Armin Keshmiri\, 25 min)\nA track-record expertise in using Cellular Matrix for OA management. \nIII) Q/A session (15min) \nREGISTER NOW >>\n\n					\n				\n					\n						Standardized Platelet-Rich Plasma for Musculoskeletal Disorders \nFor professionals involved in the management of patients suffering from musculoskeletal disorders
URL:https://library.biobridge-event.com/knowledge/event/cellular-matrix-innovation-for-osteoarthritis-management/
LOCATION:via Zoom\, Switzerland
END:VEVENT
END:VCALENDAR